Preventing staphylococcal infections by eradicating nasal carriage of Staphylococcus aureus: proceeding with caution

Review

J M Boyce. Infect Control Hosp Epidemiol. 1996 Dec.

. 1996 Dec;17(12):775-9.

doi: 10.1086/647235.

No abstract available

Comment on

Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus.
Kluytmans JA, Mouton JW, VandenBergh MF, Manders MJ, Maat AP, Wagenvoort JH, Michel MF, Verbrugh HA. Kluytmans JA, et al. Infect Control Hosp Epidemiol. 1996 Dec;17(12):780-5. doi: 10.1086/647236. Infect Control Hosp Epidemiol. 1996. PMID: 8985763 Clinical Trial.
Cost-effectiveness of perioperative mupirocin nasal ointment in cardiothoracic surgery.
VandenBergh MF, Kluytmans JA, van Hout BA, Maat AP, Seerden RJ, McDonnel J, Verbrugh HA. VandenBergh MF, et al. Infect Control Hosp Epidemiol. 1996 Dec;17(12):786-92. doi: 10.1086/647237. Infect Control Hosp Epidemiol. 1996. PMID: 8985764 Clinical Trial.
Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from Brazilian university hospitals.
Netto dos Santos KR, de Souza Fonseca L, Gontijo Filho PP. Netto dos Santos KR, et al. Infect Control Hosp Epidemiol. 1996 Dec;17(12):813-6. Infect Control Hosp Epidemiol. 1996. PMID: 8985770